Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Ana Aparicio, MD, MD Anderson Cancer Center
Videos
11/10/2022
Ana Aparicio, MD, discusses aggressive variants of metastatic castration-resistant prostate cancer, with a focus on treatment approaches for patients with androgen-indifferent disease.
Ana Aparicio, MD, discusses aggressive variants of metastatic castration-resistant prostate cancer, with a focus on treatment approaches for patients with androgen-indifferent disease.
Ana Aparicio, MD, discusses...
11/10/2022
Oncology
Conference Coverage
03/30/2022

Janelle Bradley

Janelle Bradley
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Maha Hussain, MD, FACP, FASCO, discussed PARP inhibitor targeted approaches for metastatic castration-resistant prostate cancer.
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Maha Hussain, MD, FACP, FASCO, discussed PARP inhibitor targeted approaches for metastatic castration-resistant prostate cancer.
In a presentation at the 2022...
03/30/2022
Oncology
Conference Coverage
03/30/2022

Janelle Bradley

Janelle Bradley
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Oliver Sartor, MD, discussed the evolving treatment landscape for metastatic hormone-sensitive prostate cancer.
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Oliver Sartor, MD, discussed the evolving treatment landscape for metastatic hormone-sensitive prostate cancer.
In a presentation at the 2022...
03/30/2022
Oncology
Conference Coverage
03/30/2022

Janelle Bradley

Janelle Bradley
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Bradley McGregor, MD, gave an update on the perioperative management of clear cell renal cell carcinoma.
In a presentation at the 2022 Great Debates and Updates in Genitourinary Oncology meeting, Bradley McGregor, MD, gave an update on the perioperative management of clear cell renal cell carcinoma.
In a presentation at the 2022...
03/30/2022
Oncology

Advertisement

Advertisement

Advertisement

Advertisement